NEKTAR THERAPEUTICS - NKTR
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 02, 2026 | Chief R&D Officer | S | D | 5,681.0 | 70.0 | 397,670.0 | 9,756.0 | View | |
| Jun 18, 2026 | President & CEO | S | D | 4,500.0 | 61.65 | 277,425.0 | 55,045.0 | View | |
| Jun 18, 2026 | President & CEO | S | D | 5,500.0 | 60.81 | 334,455.0 | 59,545.0 | View | |
| Jun 18, 2026 | President & CEO | S | D | 4,697.0 | 60.71 | 285,154.87 | 65,045.0 | View | |
| Jun 18, 2026 | President & CEO | S | D | 5,303.0 | 59.97 | 318,020.91 | 69,742.0 | View | |
| Jun 17, 2026 | Chief R&D Officer | S | D | 5,538.0 | 60.71 | 336,211.98 | 15,437.0 | View | |
| May 21, 2026 | Chief R&D Officer | S | D | 199.0 | 65.51 | 13,036.49 | 20,975.0 | View | |
| May 21, 2026 | President & CEO | S | D | 444.0 | 65.51 | 29,086.44 | 75,045.0 | View | |
| Feb 20, 2026 | Chief R&D Officer | S | D | 180.0 | 73.0 | 13,140.0 | 21,174.0 | View | |
| Feb 20, 2026 | President & CEO | S | D | 423.0 | 73.0 | 30,879.0 | 75,489.0 | View |